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Abstract
Aims To determine the impact of structured education promoting flexible intensive insulin therapy on rates of diabetic
ketoacidosis, and the costs associated with emergency treatment for severe hypoglycaemia and ketoacidosis in adults
with Type 1 diabetes.
Methods Using the Dose Adjustment For Normal Eating research database we compared the rates of ketoacidosis and
severe hypoglycaemia during the 12 months preceding Dose Adjustment For Normal Eating training with the rates
during the 12-month follow-up after this training. Emergency treatment costs were calculated for associated paramedic
assistance, Accident and Emergency department attendance and hospital admissions.
Results Complete baseline and 1-year data were available for 939/1651 participants (57%). The risk of ketoacidosis in
the 12 months after Dose Adjustment For Normal Eating training, compared with that before training, was 0.39 (95%
CI: 0.23 to 0.65, P < 0.001), reduced from 0.07 to 0.03 episodes/patient/year. For every 1 mmol/mol unit increase in
HbA1c concentration, the risk of a ketoacidosis episode increased by 6% (95% CI: 5 to 7%; 88% for a 1% increase), and
for each 5-year increase in diabetes duration, the relative risk reduced by 20% (95% CI: 19 to 22%). The number of
emergency treatments decreased for ketoacidosis (P < 0.001), and also for severe hypoglycaemia, including paramedic
assistance (P < 0.001), Accident and Emergency department attendance (P = 0.029) and hospital admission
(P = 0.001). In the study cohort, the combined cost of emergency treatment for ketoacidosis and severe hypoglycaemia
fell by 64%, from £119,470 to £42,948.
Conclusions Structured training in flexible intensive insulin therapy is associated with a 61% reduction in the risk of
ketoacidosis and with 64% lower emergency treatment costs for ketoacidosis and severe hypoglycaemia.
Diabet. Med. 31, 847–853 (2014)
Introduction
Individuals with Type 1 diabetes are vulnerable to ketoac-
idosis if exogenous insulin is relatively deficient and to
severe hypoglycaemia if insulin is delivered in relative
excess. Both acute complications are, at least, disabling
and, at worst, can be fatal. Whilst the number of deaths as a
result of ketoacidosis or severe hypoglycaemia is lower than
for cardiovascular disease in people with Type 1 diabetes,
these acute metabolic decompensations cause 9–13% of
deaths in adults [1,2], with a higher proportion of 20–44%
of deaths in children and young adults (excluding ketoac-
idosis at diagnosis) [1–5]. In addition to the detrimental
personal impact of ketoacidosis and severe hypoglycaemia,
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the financial cost to healthcare providers of treating these
acute complications is considerable [6]. The frequency of
ketoacidosis in adults with Type 1 diabetes is estimated to
be 0.8 to 8.6 events per 100 patient-years in the USA,
Europe and Israel [7–9]. Figures from the recently published
National Diabetes Audit [10] in the UK show that 6141
people with Type 1 diabetes were admitted to hospital once
or more with ketoacidosis over a 12-month period, which is
equivalent to an incidence of 3.32%. Each episode of
ketoacidosis costs on average ~£900 [6], equating to a total
of ~£5.5 m per year. It has been estimated that the incidence
rate for emergency treatment of severe hypoglycaemia in
people with Type 1 diabetes is ~11.5 per 100 patients-years
[11]. In that study, the associated cost was estimated to be
~£6.5 m across the UK. More recently, in 2010, the
estimated costs of severe hypoglycaemia were calculated at
£13.6 m for England, although in that study no differenti-
ation was made between Type 1 and Type 2 diabetes [12].
Among people with established Type 1 diabetes, ketoaci-
dosis and severe hypoglycaemia are potentially avoidable if
exogenous insulin is administered appropriately. As Type 1
diabetes is a long-term condition requiring intensive daily
self-management, high-quality education and training are
essential. The Dose Adjustment For Normal Eating (DAFNE)
[13] structured education programme has now been delivered
to > 28 000 adults with Type 1 diabetes in the UK. It was
primarily designed to increase dietary freedom and improve
blood glucose control and, thereby, reduce the risk of
long-term microvascular complications. An earlier observa-
tional study reported a reduced incidence of severe hypo-
glycaemia and improved awareness of hypoglycaemic
symptoms after DAFNE training [14]. The German model
[15] on which DAFNE is based has also previously reported a
reduction in the incidence of both ketoacidosis and severe
hypoglycaemia (defined as a reduction in hypoglycaemic coma
or the need for intravenous glucose) in a high-risk cohort [16].
As the financial costs of ketoacidosis and severe hypoglyca-
emia are substantial, we undertook a detailed retrospective
analysis among a large cohort of adults with Type 1 diabetes
attending a DAFNE course. Our aim was to determine the
impact of DAFNE training on the incidence of emergency
treatment of both acute complications, and to calculate the
associated costs to the healthcare system based on the level of
healthcare input required and the length of hospital stay. In
addition, we examined the relationship between HbA1c and
the incidence of ketoacidosis.
Patients and Methods
The DAFNE research database was created as part of a
programme of research supported by the UK National
Institute of Health Research. Biomedical and psychosocial
data are collected from participants attending DAFNE
courses from selected secondary care diabetes units (21 in
total) as part of their routine clinical care. HbA1c concen-
tration was measured at local Diabetes Control and
Complications Trial (DCCT)-aligned laboratories, with a
normal range considered to be 35–48 mmol/mol. Patients
participating in DAFNE training at these centres are invited
to give consent for their yearly biomedical and psychosocial
data to be stored anonymously on the database. Clinical staff
contact participants directly and examine medical records to
gather retrospective biomedical data, specifically enquiring
about any episodes of ketoacidosis or severe hypoglycaemia,
the level of healthcare input required, and, if admitted, the
length of stay. Severe hypoglycaemia is defined as an episode
requiring the assistance of a third party in order to recover
[17,18]. Ketoacidosis is defined as a physician-diagnosed
episode requiring admission to hospital. All records of
participants recruited between December 2008 and June
2011 were included in the present study. Emergency treat-
ment costs were calculated for paramedic assistance, Acci-
dent and Emergency department attendance and hospital
admissions (based on age and length of stay), using NSRC1
NHS Trust reference cost schedule 2010–2011 [6].
Ethics approval for this research database was approved
by the Trent Research Ethics Committee, 10/10/08, Rec No.
08/H0405/48, and participants are required to give written
informed consent.
Statistical analyses
We constructed negative binomial models with a fixed factor
for before vs after DAFNE training and a population-aver-
aged exchangeable correlation to allow for clustering by
centre. This allows modelling of variables which are
over-dispersed relative to a Poisson model. We assumed that
rates for individuals came from a distribution with a fixed,
but non-zero variance. These models produce relative risks,
95% CIs and P values. A second negative binomial model
What’s new?
• Diabetic ketoacidosis is a common but potentially fatal
medical emergency. Among people with Type 1
diabetes there are ~6000 episodes per year in the
UK but, until now, few interventions to reduce episodes
have been reported. Both ketoacidosis and severe
hypoglycaemia have a major impact on quality of life
and attract considerable emergency treatment costs.
• Our data suggest that structured training in insulin
self-management reduces both the rates of ketoacidosis
and severe hypoglycaemia requiring emergency treat-
ment, and their associated costs. This study reinforces
the importance of making high-quality structured
education more readily available to people with Type
1 diabetes.
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with an interaction between the covariate for duration of
diabetes and the fixed factor for before vs after DAFNE
training was fitted to see if the relationship between
ketoacidosis and duration of diabetes was different after
the training course. In the same manner, a model with HbA1c
as the covariate was used to determine if the relationship
between ketoacidosis and HbA1c was altered before and after
DAFNE training.
For binary data, logistic models with a fixed factor for
before vs after DAFNE with a population-averaged
exchangeable correlation to allow for clustering on centre
were used. These models produce odds ratios, 95% CIs and
P values. Models were fitted using SPSS version 19, and the
plots were performed in R (http://cran.r-project.org/). For
both types of data, a P value <0.05 was considered to
indicate statistical significance.
Results
Records from 1651 patients [49.6% women, baseline mean
(SD) age 39.4 (13.7) years, mean (range) duration of diabetes
16.5 (0–65) years] were identified and, of these, 939 (57%)
had paired HbA1c concentration and severe hypoglycaemia
data at baseline and at first annual follow-up. In order to
exclude any episodes of ketoacidosis experienced at diag-
nosis, only participants with a duration of diabetes of
≥2 years at baseline were included in the ketoacidosis
analyses (n = 864). The mean (SD) time to collection of first
follow-up data was 388 (48) days. At this follow-up, the
mean (SD) HbA1c concentration had decreased from 71 (17)
mmol/mol [8.7 (1.5)%] to 69 (16) mmol/mol [8.4 (1.5)%],
mean (SD) difference of -3 (-0.2), (95% CI: -3 [-0.3] to -2
[-0.2], P < 0.001). The participants excluded because of
insufficient data at follow-up were slightly younger, and had
shorter diabetes duration, higher HbA1c concentrations and
more episodes of severe hypoglycaemia and ketoacidosis.
Similar proportions of those included/excluded were women
(Table 1).
The number and type of events requiring emergency
treatment with healthcare input in the 12 months before
and after DAFNE training are summarized in Table 2. In the
year before DAFNE training, 41 participants (4.7%) with
paired data experienced a total of 57 episodes of ketoacidosis
requiring admission to hospital, compared with 18 partici-
pants (2.1%) reporting 22 episodes in the year after DAFNE
training. This represents a 56% reduction in the number of
people experiencing ketoacidosis over the course of 1 year
(odds ratio=0.42, 95% CI: 0.25 to 0.71, P = 0.001). The
number of individuals with multiple episodes of ketoacidosis
also decreased by 73% from 11 (1.3%) to 3 (0.3%; odds
ratio =0.28, 95% CI: 0.10 to 0.79, P = 0.017). The estimated
relative risk for ketoacidosis before vs after DAFNE was 0.39
(95% CI: 0.23 to 0.65), P < 0.001, reduced from 0.07 to 0.03
episodes per patient per year; therefore, participants had a
61% reduced risk of an episode of ketoacidosis after DAFNE
training compared with before the training.
In participants with paired data, at baseline, those with a
history of ketoacidosis requiring admission within the
preceding 12 months, when compared with those without
an episode, were younger [34.4 (SD 11.6) vs 41.7 (SD 13.7)
years, difference of -7.2 (95% CI: -11.5 to -3.0), P = 0.001]
and had a shorter duration of diabetes [12.3 (SD 7.7) vs 19.2
(SD 13.1) years, difference -6.8 (95% CI: -10.9 to -2.8),
P = 0.001], but there was no gender difference between the
two groups [56.1 vs 50.9% female, difference 5.2% (95%
CI: -10.8 to 21.2), P = 0.517]. Using a negative binomial
model, the relative risk of ketoacidosis in those with at least
one ketoacidosis episode at baseline compared with those
with no ketoacidosis at baseline was estimated as 9.35 (95%
CI: 2.75 to 31.75). Individuals experiencing ketoacidosis in
the 12 months before DAFNE training had a significantly
higher HbA1c concentration compared with the remainder of
the cohort: mean (SD) 88 (22) mmol/mol [10.3 (2.0)%] vs 71
(16) mmol/mol [8.6 (1.4)%], mean (SD) difference 18 [(1.6);
95% CI: 13 (1.2) to 23 (2.1), P < 0.001]. Likewise, when the
whole baseline dataset was analysed, those individuals with a
history of ketoacidosis within the previous 12 months had
significantly higher HbA1c concentrations: mean (SD) 87 (20)
mmol/mol [10.1 (1.8)%] vs 72 (17) mmol/mol [8.7 (1.5)%],
difference 15 [(1.4); 95% CI: 11 (1.1) to 19 (1.7); P < 0.001].
Table 1 Demographics of participants included in the analysis, compared with those excluded as lost to follow-up
Mean (SD) baseline values
Difference (SD) 95% CI
P value of
the difference
Subjects included:
n = 939
Subjects excluded:
n = 712
HbA1c concentration, mmol/mol
HbA1c concentration,%
71 (17)
8.7 (1.5)
75 (19)
9.0 (1.7)
3 (0.3)
(2 (0.2), 5 (0.5)
2, 5
0.2, 0.5
<0.001
Age, years 41.0 (13.6) 37.7 (13.3) -3.2 -4.5, -1.9 <0.001
Gender, % female 47.2 51.4 4.2 -0.7, 9.1 0.087
Duration of diabetes, years 17.4 (13.4) 15.5 (11.6) -1.9 -3.1, -0.7 0.002
Rate of severe hypoglycaemia/
patient/year
0.82 1.25 1.53* 1.39, 1.69 <0.001
Rate of ketoacidosis/patient/year 0.07 0.12 1.80* 1.29, 2.52 0.001
*Relative risk.
ª 2014 The Authors.
Diabetic Medicine published by John Wiley & Sons Ltd on behalf of Diabetes UK. 849
Research article DIABETICMedicine
Within our cohort, the estimated relative annual risk of an
episode of ketoacidosis for a 1-mmol/mol increase in HbA1c
concentration was 1.06 (1.88 for a 1% increase [95% CI:
1.05 (1.65) to 1.07 (2.13); P < 0.001]; therefore for every
1-mmol/mol unit increase in HbA1c concentration, the risk of
a ketoacidosis episode increased by 6% (88% for a 1%
increase). In our model, the equations for an episode of
ketoacidosis dependent on HbA1c before DAFNE training,
equation 1, and after DAFNE training, equation 2, are shown
below, where HbA1c is expressed in mmol/mol. This is shown
graphically in Fig. 1 (shaded areas indicate 95% CI bands).
 Equation 1 = exp(-7.385 + 0.058 9 HbA1c)
 Equation 2 = exp(-8.178 + 0.058 9 HbA1c)
The interaction between the fixed factor for before vs after
DAFNE training and the covariate for HbA1c was not
significant (P = 0.483); therefore, the increase in risk of
ketoacidosis with increased HbA1c concentration was the
same before and after DAFNE.
The estimated relative risk of ketoacidosis for a 1-year
increase in diabetes duration was 0.96, (95% CI: 0.94 to
0.98); therefore, for every 1-year increase in duration, the
risk of a ketoacidosis hospital admission decreased by 4%
and, for every 5-year increase in duration, the risk of a
ketoacidosis hospital admission decreased by 20%. In our
model, the equation for a ketoacidosis hospital admission
dependent on duration of diabetes before DAFNE training is
shown as equation 3, and after DAFNE training, as equation
4, below. This is shown graphically in Fig. 2 (shaded areas
indicate 95% CI bands).
 Equation 3 = exp(-2.006 – 0.045 9 duration)
 Equation 4 = exp(-2.952 – 0.045 9 duration)
The total number of nights spent in hospital as a result of
ketoacidosis was 210 in the 12 months before DAFNE
training and 67 in the following 12 months, (relative risk
0.32 (95% CI: 0.19 to 0.54) P < 0.001). The number of
patients admitted with hypoglycaemia (P < 0.001), requiring
paramedic assistance (P < 0.001), and/or requiring Accident
and Emergency department attendance (P = 0.029) were all
significantly reduced. Likewise, the total number of nights
spent in hospital as a result of hypoglycaemia fell from 80 to
21 (P < 0.001). Within this cohort there were no deaths
Table 2 Number of episodes of severe hypoglycaemia and ketoacidosis in the 12 months before compared with the 12 months after Dose
Adjustment For Normal Eating training
Before DAFNE
training (baseline)
12 months after
DAFNE training
Absolute
risk
*Relative risk
(95% CI)
P value
of the
differenceTotal Range Rate Total Range Rate
Admissions for ketoacidosis 57 0–3 0.07 22 0–3 0.03 0.04 0.39
(0.23, 0.65)
<0.001
Nights spent in hospital as a result of ketoacidosis 210 0–17 0.24 67 0–9 0.08 0.16 0.32
(0.19, 0.54)
<0.001
Admissions for severe hypoglycaemia 30 0–2 0.03 10 0–2 0.01 0.02 0.33
(0.17, 0.64)
0.001
Nights spent in hospital as a result of hypoglycaemia 80 0–21 0.09 21 0–8 0.02 0.07 0.32
(0.20, 0.54)
<0.001
Episodes requiring paramedics 167 0–6 0.18 51 0–5 0.05 0.13 0.30
(0.19, 0.46)
<0.001
Episodes requiring Accident and Emergency
department attendance
53 0–5 0.06 20 0–3 0.02 0.04 0.37
(0.15, 0.90)
0.029
Episodes requiring both paramedics and Accident
and Emergency department attendance
52 0–5 0.06 18 0–3 0.02 0.04 0.34
(0.13, 0.89)
0.028
DAFNE, Dose Adjustment For Normal Eating.
*Negative binomial models with a fixed factor for before vs after DAFNE with a population-averaged exchangeable correlation to allow for
clustering on centre were used for data which are counts. These models produce relative risks, 95% CIs and P values.
FIGURE 1 Effect of HbA1c concentration on rates of ketoacidosis
admissions before and after Dose Adjustment For Normal Eating
training.
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attributable to ketoacidosis or hypoglycaemia. The costs of
all diabetes emergency care are shown in Table 3. In the
12 months before DAFNE training, the total cost of emer-
gency treatments for ketoacidosis and severe hypoglycaemia
in this cohort was £119,470, compared with £42,947 in the
12 months after DAFNE training. This represents a 64%
reduction in costs and a saving of £81 per participant over
1 year. For comparison, the cost of a DAFNE course is on
average £359 per participant [19]. Just over half the savings
(51%) were as a result of fewer ketoacidosis admissions, and
the remainder were attributable to the combination of
treatments for severe hypoglycaemia.
Discussion
In a large-scale cohort of participants in DAFNE training, we
have shown that the relative risk of ketoacidosis was reduced
by 61% in the year after DAFNE training compared with the
year before. This compares favourably with a study reporting
the German experience, in which the incidence fell by 55%
[16], particularly as that study was conducted in individuals
at high risk of ketoacidosis, who had experienced two or
more episodes in the year before training. Second to a history
of ketoacidosis, the most important reported factor predict-
ing ketoacidosis is higher HbA1c concentration [8,9,20]. In
the present cohort, those experiencing an episode of ketoac-
idosis did have significantly higher HbA1c concentrations
than the remainder of the cohort. We calculated that for
every 1-mmol/mol unit increase in HbA1c, there was a 6%
increased risk of an episode of ketoacidosis (88% for a 1%
increase). This relationship was unchanged by the impact of
DAFNE training, although the overall incidence was mark-
edly reduced. The substantial reduction in risk of ketoacido-
sis occurred despite only a modest fall in overall HbA1c
concentration. The improvement in ketoacidosis incidence
may be attributable to greater participant understanding of
the pathogenesis of ketoacidosis and its management, as this
is an integral component of the curriculum. For example,
training in relation to sickness management includes guid-
FIGURE 2 Effect of duration of diabetes on rates of ketoacidosis
admissions before and after Dose Adjustment For Normal Eating
training.
Table 3 Costs of emergency treatment in the 12 months before and after attendance of a Dose Adjustment For Normal Eating training course
Number of episodes
Unit cost of
emergency
treatment
Total emergency treatments costs
12 months
before DAFNE
12 months
after DAFNE
12 months
before DAFNE
12 months
after DAFNE
Emergency treatment for ketoacidosis
Length of stay = 1 night 8 5 £405.57* £3,244.56 £2,027.85
Length of stay >1 night 49 17 £1,176.53* £57,649.97 £20,001.01
Total cost of ketoacidosis treatments £60,894.53 £22,028.86
Hypoglycaemia in patients <70 years of age
Length of stay = 1 night 16 5 £385.00 £6,160.00 £1,925.00
Length of stay >1 night 7 3 £1,177.00 £8,239.00 £3,351.00
Hypoglycaemia in patients >70 years of age
Length of stay =1 night 0 1 £418.00 £0.00 £418.00
Length of stay >1 night 1 1 £1,657.00 £1,657.00 £1,657.00
Hypoglycaemia requiring:
Paramedic assistance 167 51 £222.48 £37,154.13 £11,346.47
Accident and Emergency department
attendance and no admission
24 10 £110.85 £2,660.36 £1,108.48
Accident and Emergency department
attendance and admission
29 10 £93.28 £2,705.04 £932.77
Total cost of hypoglycaemia treatments £58,575.53 £20,918.72
Total cost of emergency treatments £119,470.06 £42,947.58
Mean cost of emergency treatments / patient £127.23 £45.74
DAFNE, Dose Adjustment For Normal Eating.
*All episodes occurred in patients <70 years of age.
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ance on when to take supplemental insulin doses at 10 or
20% of usual total daily insulin dose, based on blood glucose
and blood or urine ketone levels. In addition, our data
confirm that those with a longer duration of diabetes are less
likely to experience an episode of ketoacidosis; in this cohort,
for each 5-year increase in duration, the risk of ketoacidosis
was reduced by 20%. We excluded episodes of ketoacidosis
at presentation of newly diagnosed Type 1 diabetes.
In recent years in the UK, efforts have been made to
improve the management of ketoacidosis by providing
national guidelines [21] and by developing diabetes specialist
inpatient teams to decrease lengths of stay and improve
patient safety [22,23]. Detailed data on the incidence of
ketoacidosis and the effect of these changes on admission
rates are lacking. Structured diabetes education is now a
national standard, although access remains patchy [24]. In
researching the effectiveness of the DAFNE programme, we
have attempted to follow the Medical Research Council
guidance for the evaluation of complex interventions, and
the present study was conducted as an evaluated roll-out
[25]. The recently published National Diabetes Audit [10]
states that ‘there is an imperative to reduce ketoacidosis
everywhere’, but published reports of interventions designed
to reduce episodes of ketoacidosis are relatively scarce. One
strategy used in young adults in Australia, after-hours
telephone support, reported a reduction in ketoacidosis
admissions of one-third [20]. Amongst adolescents, intensive
home-based family therapy has been shown to reduce
ketoacidosis admissions in one centre in the USA, with some
of the costs offset by reductions in admissions [26].
Based on the latest National Diabetes Audit data, the
annual cost of ketoacidosis admissions is £5.5 m. As a result
of reduced incidence of ketoacidosis in the present cohort,
expenditure on ketoacidosis admissions was decreased by
64%; thus, the potential for cost saving across the UK is
considerable. The cost of providing emergency care for
severe hypoglycaemia to adults with Type 1 diabetes includes
not only inpatient expenditure, but also paramedic and
Accident and Emergency assistance costs. The total cost to
the NHS for people with Type 1 diabetes is likely to be in the
region of ~£6.5 m [11]. The number of paramedic call-outs,
Accident and Emergency department attendances and hos-
pital admissions for the treatment of severe hypoglycaemia
were all significantly reduced in the year after DAFNE
training, compared with the year before. We have also
calculated that the total cost of emergency treatment of
hypoglycaemia was reduced by 64% in this cohort, in the
year after DAFNE training.
While this work has demonstrated significant reductions in
episodes of ketoacidosis and hypoglycaemia, and associated
costs, there are some important limitations. It is possible that
those participants excluded from the analysis because of
incomplete data collection at follow-up may not have fared so
well, although at baseline they had higher rates of both
ketoacidosis and severe hypoglycaemia. The data were
collected retrospectively and so recording of events may have
been incomplete. As with any observational study, in the
absence of a control group we cannot assume that the benefits
achieved were solely as a result of the DAFNE intervention.
In addition, we do not know how representative this cohort is
in comparison with the population of people with Type 1
diabetes as a whole within the UK, for example, in terms of
socioeconomic status, physical and mental health. A strength
of the present study is the large number of unselected patients
in whom data was collected during routine clinical care. The
annual rates of ketoacidosis and severe hypoglycaemia after
DAFNE training may be overestimated by 6% as the mean
follow-up was slightly longer than 1 year (388 as opposed to
365 days). In addition, at baseline we do not know the
accuracy with which patients have recalled events over the
preceding year; however, there is evidence to show that severe
hypoglycaemic events are recalled accurately by patients up
to 1 year [27], and both severe hypoglycaemia and ketoac-
idosis events were corroborated by review of medical notes.
As follow-up data are collected annually, in the future we aim
to determine whether the reductions in requirement for
emergency treatment (and the cost savings) are sustained
beyond the first year. It is noteworthy that we have only
considered the direct emergency costs associated with
ketoacidosis and severe hypoglycaemia. Other indirect costs,
such as loss of work productivity and increased use of blood
glucose monitoring strips, are associated both with severe
hypoglycaemia and non-severe hypoglycaemia [28,29]; thus,
the overall cost savings reported in the present paper are
likely to be underestimates of the true costs of these adverse
events as a whole.
In conclusion, admissions as a result of ketoacidosis and
the frequency of severe hypoglycaemia requiring healthcare
professional assistance are significantly reduced after
DAFNE skills training. In routine clinical care, the benefits
of structured training in flexible intensive insulin therapy
include not only improvements in glycaemic control and
quality of life [13,14,30] but also substantial reductions in
episodes of ketoacidosis, severe hypoglycaemia and emer-
gency treatment costs.
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